Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Dublin, Feb. 25, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/zmzmmz/artificial_tears) has announced the addition of the "Artificial Tears - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 68 companies including many key and niche players such as:
- Abbott Medical Optics Inc. (US)
- Allergan, Inc. (US)
- Akorn, Inc. (US)
- Bausch & Lomb Incorporated. (US)
- Johnson & Johnson (US)
- Novartis International AG (Switzerland)
- Alcon, Inc. (Switzerland)
- Santen Pharmaceuticals Co, Ltd. (Japan)
- Novagali Pharma S.A. (France)
Key Topics Covered:
1. Industry Overview
2. Noteworthy Market Trends
3. Dry Eye Syndrome
4. Product Overview
5. Product Launches/Approvals/ Introductions
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 68 (including Divisions/Subsidiaries 74)
- The United States (25)
- Canada (3)
- Japan (4)
- Europe (22)
- - France (3)
- - Germany (3)
- - The United Kingdom (5)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (17)
- Africa (2)
- Middle-East (1)
For more information visit http://www.researchandmarkets.com/research/zmzmmz/artificial_tears
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Optical
